Ventilator-associated pneumonia: the prevention bundle
- Concept
A lung infection that can start after a patient has been on a breathing machine for some days, and the routine steps that help prevent it.
What it is
Ventilator-associated pneumonia (VAP) is pneumonia that develops more than 48 hours after tracheal intubation. It is one of the commonest infections in intensive care and prolongs ventilation and ICU stay. The tube bypasses the larynx, impairs cough and mucociliary clearance, and lets secretions pooled above the cuff, colonised by bacteria from the mouth, sinuses and stomach, leak past it into the lower airway; a biofilm also forms inside the tube. Early VAP, in the first days, is more often caused by community organisms such as Streptococcus pneumoniae, Haemophilus influenzae and methicillin-sensitive Staphylococcus aureus, while late VAP and patients with recent antibiotics or hospital stays are at risk of resistant Gram-negative bacilli such as Pseudomonas aeruginosa, Acinetobacter and Klebsiella, and of methicillin-resistant S. aureus. Diagnosis has no perfect test: suspect it with a new or progressive infiltrate plus fever, purulent secretions, a rising white cell count or worsening oxygenation, and take lower airway cultures before starting or changing antibiotics. Prevention works best as a bundle applied every day: avoid intubation when non-invasive support is safe, keep sedation light with daily interruption paired with a spontaneous breathing trial, raise the head of the bed, give oral care, drain subglottic secretions where the tube allows, keep cuff pressure in range, avoid unnecessary circuit changes and mobilise early. The best prevention of all is the shortest safe time on the ventilator.
Key points
- Risk factors: longer ventilation, reintubation, supine position, deep sedation, enteral feeding with reflux, transport, older age, chronic lung disease.
- Diagnosis combines a new or progressive infiltrate with at least two of fever or hypothermia, purulent secretions and abnormal white cell count.
- Lower airway samples (tracheal aspirate or bronchoalveolar lavage) should be taken before antibiotics are started or changed.
- Ventilator-associated events surveillance tracks sustained worsening of oxygenation rather than a clinical diagnosis of pneumonia.
Components
- Head of bed elevated about 30–45 degrees unless contraindicated.
- Daily sedation interruption paired with a spontaneous breathing trial.
- Oral care with tooth brushing; routine chlorhexidine mouthwash is now debated.
- Endotracheal tubes with subglottic secretion drainage when ventilation is expected to last more than a few days.
- Cuff pressure kept within the recommended range; avoid routine circuit changes unless soiled.
- Early mobilisation, careful enteral feeding and avoiding unnecessary transfers.
How it works
- Raising the head of the bed reduces reflux and aspiration of gastric contents.
- Lighter sedation and daily breathing trials shorten ventilation, which reduces exposure.
- Draining secretions above the cuff and keeping the cuff sealed reduce the volume that leaks into the trachea.
- Oral care lowers the bacterial load in the mouth that colonises those secretions.
Early and late VAP: likely organisms
| Type | Typical organisms | Notes |
|---|---|---|
| Early (first days), no risk factors | Streptococcus pneumoniae, Haemophilus influenzae, methicillin-sensitive S. aureus, enteric Gram-negatives | Narrower empirical therapy may be enough |
| Late, or recent antibiotics or hospitalisation | Pseudomonas aeruginosa, Acinetobacter, Klebsiella and other resistant Gram-negatives, MRSA | Broad empirical therapy guided by local resistance, then de-escalate |
In practice
- Suspect VAP when a ventilated patient has new fever, purulent secretions and worsening oxygenation with a new infiltrate.
- Start empirical antibiotics promptly when VAP is likely, covering resistant organisms if risk factors exist, guided by the local antibiogram.
- Reassess at 48–72 hours with cultures: narrow or stop antibiotics, and aim for a short course when the patient responds.
- Consider other causes of fever and infiltrates: atelectasis, ARDS, pulmonary oedema, embolism, drug fever or another infection.
- Stress ulcer prophylaxis may slightly increase pneumonia risk: give it to patients with a clear indication only.
Next step
- Check the bundle on every round: head of bed, sedation target and interruption, breathing trial, oral care, cuff pressure, subglottic drainage.
- If VAP is suspected, send a lower airway sample, blood cultures and a chest X-ray before antibiotics; review at 48–72 hours.
- Call a senior or infectious diseases for septic shock, resistant organisms or failure to improve on treatment.
- Track VAP rates and bundle compliance in the unit and feed them back to the team.
Test yourself
Think of the answer, then tap the question to see it.
How is ventilator-associated pneumonia defined by timing?
Pneumonia that develops more than 48 hours after tracheal intubation.
What is the main mechanism by which VAP develops?
Microaspiration of colonised oropharyngeal and gastric secretions that pool above the tube cuff and leak past it, plus biofilm in the tube.
What are four elements of a VAP prevention bundle?
Head of bed elevation, daily sedation interruption with a spontaneous breathing trial, oral care and subglottic secretion drainage; also cuff pressure checks.
Which organisms should empirical therapy cover in late VAP?
Resistant Gram-negative bacilli such as Pseudomonas, Acinetobacter and Klebsiella, and MRSA, according to local resistance patterns.
Elsewhere in DurgiPedia
- Airway suctioning: oral, nasal and artificial airways
- Tracheostomy care
- Patient positions: Fowler, supine, lateral, prone and others
- Nasogastric tube: insertion and checking its position
- Dysphagia and aspiration precautions
Connections
In Pharmacology1
Educational content; it does not replace supervised training, your institution's protocols or the anaesthetist's or intensivist's decision. It contains no doses and no ventilator or infusion settings.
Sources: Ventilator-Associated Pneumonia (StatPearls (NCBI Bookshelf), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.